Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Ready-to-use software suite implementing fully individualized neurofeedback protocols for ADHD remediation in clinical setups

Project description

Personalised neurofeedback for ADHD

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition marked by inattention, impulsivity, and hyperactivity that can impair learning, behaviour, and quality of life. Current treatments often fall short in tailoring interventions to individual brain dynamics. The ERC-funded FOCUS project will develop a plug-and-play software suite for clinics, combining fMRI- and EEG-based neurofeedback tailored to each patient’s brain connectivity. The approach targets inattention, impulsivity, and attentional flexibility, using fMRI to drive change, followed by EEG to consolidate it. With automated tracking of brain and behavioural progress, the protocol is designed to reduce symptoms, enhance cognitive control, and improve quality of life. Delivered as an easy-to-use software solution for clinical use, FOCUS brings cutting-edge neuroscience to ADHD care.

Objective

We propose to develop a ready-to-use software suite implementing fully individualized neurofeedback protocols for ADHD remediation in clinical setups. These protocols will be tailored to each participant’s initial brain functional connectivity, and will combine fMRI- and EEG-neurofeedback to enhance and restore attentional control. The fMRI-neurofeedback will be driven by three specific functional markers derived from individual participant resting-state fMRI brain patterns, respectively targeting inattention, impulsivity and attentional flexibility. The EEG- neurofeedback will intervene in a second step and will specifically target the connectivity changes induced by the fMRI- neurofeedback. These neurofeedback protocols will be tailored to enhance cognitive functions, decrease ADHD symptoms and improve quality of life. Their innovation potential will rely on the combination of unique features optimizing the neurofeedback to individual participant neurophysiology and to achieving transfer of efficiency from within the protocol to real life. The software suit will allow automated tracking of changes in cognitive function, in brain functional connectivity and associated dynamics, in ADHD clinical scores as well as in quality-of-life self-reports. The project will be organized in four distinct work packages: a test work package, a research work package, a software development work package and an IPR, knowledge transfer and market analysis work package.

The entire protocol will be released as an easy-to-install and use software suit, allowing clinical ADHD units having access to an fMRI and to an EEG to implement seamlessly. The outcome will be distributed to beta-testing ADHD clinical units and appropriate knowledge transfer plans will be built to maximize societal impact. In parallel, the software neurofeedback suit will be patented and market analysis will be performed in view of commercialization as a patented medical remediation device.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-POC

See all projects funded under this call

Host institution

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Net EU contribution
€ 150 000,00
Address
RUE MICHEL ANGE 3
75794 Paris
France
Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Links
Total cost
No data

Beneficiaries (1)